Kanker hati Dokter Terbaik di Israel - TOP-19 dokter

Prof. Merimsky memimpin unit sarkoma di Sourasky Medical Center, menghadirkan keahlian mendalam dalam pengobatan kanker hati dengan pengalaman lebih dari 30 tahun.

• Spesialis dalam onkologi jaringan lunak dan tulang
• Anggota fakultas ESMO untuk sarkoma
• Mantan Ketua Onkologi di Universitas Tel-Aviv
• Penelitian ekstensif dalam imunologi tumor

Dr. Pelles Sharon berspesialisasi dalam perawatan kanker hati tingkat lanjut di Sourasky Medical Center, termasuk kemoterapi dan terapi target. Ia berkontribusi aktif dalam penelitian onkologi, memastikan perawatan pasien berbasis bukti.

• Melakukan reseksi hati dan kemoembolisasi untuk kanker hati
• Menjadi ahli dalam terapi target dan pendekatan imunoterapi
• Melakukan penelitian mengenai sikap pasien terhadap uji klinis

Prof. Arber mengkhususkan diri dalam pencegahan dan diagnosis kanker saluran pencernaan, bukan hanya mengobatinya. Beliau mengepalai Pusat Pencegahan Kanker di Sourasky Medical Center.

• Memiliki pengalaman lebih dari 30 tahun dalam onkologi gastrointestinal
• Menerbitkan lebih dari 300 makalah penelitian tentang kanker saluran pencernaan
• Kepala Pusat Pencegahan Kanker di Ichilov
• Pengalaman fellowship dan penelitian di rumah sakit terkemuka di AS
• Anggota masyarakat penelitian onkologi internasional terkemuka

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center. He specializes in HPB and robotic surgery for diseases of the liver, pancreas, and bile ducts, and for gastrointestinal neuroendocrine tumors. He also performs adrenal, spleen, and stomach surgery. Forbes listed him among Israel’s top physicians.

He advances minimally invasive robotic and laparoscopic techniques. The aim is better precision and faster recovery.

Credentials: Senior Lecturer at Tel Aviv University. Member of ASTS and IHPBA. Completed HPB and abdominal transplant fellowships at the Thomas E. Starzl Transplantation Institute. Board certified in General Surgery (Israel), Abdominal Organ Transplantation (ASTS), and HPB Surgery (University of Pittsburgh). He has published in Cancer Research, the Journal of the American College of Surgeons, and the European Journal of Surgical Oncology.

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Kepala Divisi Onkologi di Pusat Medis Sourasky utama di Tel Aviv – Prof. Wolf memimpin tim tingkat atas.

• Spesialisasi dalam onkologi medis dan penyakit dalam di Pusat Medis Sheba
• Menyelesaikan fellowship postdoctoral di Pusat Medis Cedar-Sinai UCLA
• Anggota perkumpulan onkologi utama, termasuk ASCO dan AACR
• Dosen senior di Fakultas Kedokteran Sackler Universitas Tel-Aviv

Dr. Ron Greenberg adalah spesialis bedah perut terkemuka yang melakukan prosedur Whipple baik secara terbuka maupun invasif minimal untuk kanker hati.

• Memiliki lebih dari 20 tahun pengalaman bedah
• Mengetuai Departemen Bedah Kolorektal di Sourasky Medical Center
• Menjadi ahli dalam prosedur kompleks termasuk teknik Whipple

Lebih dari 28 tahun pengalaman mengobati kanker hati dan gastrointestinal – Dr. Ben-haim spesialis dalam bedah onkologi kompleks di Sourasky Medical Center.

• Ahli dalam operasi Whipple untuk kanker pankreas
• Fokus eksklusif pada onkologi gastrointestinal
• Melakukan intervensi lanjutan untuk tumor hati

Salah satu ahli bedah Whipple terbaik di Israel, Dr. Klauzner spesialis dalam prosedur kompleks gastrointestinal dan pankreas. Saat ini beliau mengepalai Departemen Bedah di Sourasky Medical Center (Ichilov).

• Pengalaman bedah lebih dari 45 tahun
• Ahli dalam bedah kanker hati, kolorektal, dan pankreas
• Spesialisasi mencakup prosedur Whipple yang kompleks
• Memegang peran kepemimpinan senior di pusat medis akademik utama

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.

She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.

Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.

Dr. Zalmanova berspesialisasi dalam radioterapi untuk kanker hati di Assuta Medical Center, sebuah rumah sakit terkemuka di Israel.

• Keahlian terfokus dalam perawatan radioterapi
• Bekerja di fasilitas medis tingkat atas
• Berdedikasi pada perawatan pasien yang dipersonalisasi

Kepala Institut Onkologi sejak 1994 – Tamar Jablonski-Perec memimpin perawatan kanker di Hadassah Medical Center dengan keahlian selama puluhan tahun.

• Spesialisasi dalam pengobatan kanker hati dengan pelatihan internasional
• Profesor Onkologi di Hebrew University
• Anggota dari berbagai komunitas kanker internasional
• Penerima beasiswa bergengsi Hadassah Medical School

Profesor Rifaat Safadi berspesialisasi dalam pengobatan penyakit hati sebagai kepala unit penyakit hati di Hadassah Medical Center. Karyanya mencakup modulasi imun pada fibrosis hati.

• Pengalaman lebih dari 30 tahun di bidang gastroenterologi dan hepatologi
• Magang di Sinai School of Medicine bersama pakar penyakit hati Profesor Scott Friedman
• Penerima berbagai penghargaan untuk penelitian fibrosis hati
• Penulis berbagai artikel dan anggota asosiasi studi hati internasional
• Menjadi anggota dewan redaksi jurnal Clinical Science

Dr. Alexander Beny memimpin Layanan Keganasan Gastrointestinal di Rambam Medical Center, yang berspesialisasi dalam pengobatan kanker hati.

• Onkolog bersertifikat dengan pelatihan di bidang onkologi medis dan radiasi
• Pakar onkologi gastrointestinal – mengepalai klinik kanker khusus
• Terlatih dalam teknik brakiterapi modern di ESTRO
• Fasih berbahasa Inggris dan Ibrani untuk pasien internasional